Compare LUNG & VLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LUNG | VLT |
|---|---|---|
| Founded | 1995 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.6M | 71.5M |
| IPO Year | 2020 | N/A |
| Metric | LUNG | VLT |
|---|---|---|
| Price | $2.22 | $11.11 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $6.81 | N/A |
| AVG Volume (30 Days) | ★ 986.2K | 22.9K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.80% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.64 |
| Revenue | ★ $91,664,000.00 | N/A |
| Revenue This Year | $9.21 | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | ★ N/A | $16.69 |
| Revenue Growth | ★ 15.59 | N/A |
| 52 Week Low | $1.31 | $9.29 |
| 52 Week High | $9.37 | $10.93 |
| Indicator | LUNG | VLT |
|---|---|---|
| Relative Strength Index (RSI) | 52.16 | 47.55 |
| Support Level | $2.16 | $11.06 |
| Resistance Level | $2.65 | $11.15 |
| Average True Range (ATR) | 0.19 | 0.06 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 36.43 | 63.41 |
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
Invesco High Income Trust II is a diversified, closed-end management investment company. Its investment objective is to provide high current income, while seeking to preserve shareholders' capital through investment in a professionally managed, diversified portfolio of high-income producing fixed-income securities.